| Julie Konstantino, | |
|
209 Cherry St, Milford, CT 06460-3501 | |
| (203) 874-5437 | |
| Not Available |
| Full Name | Julie Konstantino |
|---|---|
| Gender | Female |
| Speciality | Speech-language Pathologist |
| Location | 209 Cherry St, Milford, Connecticut |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1306256144 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 235Z00000X | Speech-language Pathologist | 004553 (Connecticut) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Julie Konstantino, 209 Cherry St, Milford, CT 06460-3501 Ph: (203) 874-5437 | Julie Konstantino, 209 Cherry St, Milford, CT 06460-3501 Ph: (203) 874-5437 |
News Archive
A new approach to stimulating immune cells enhances their anticancer activity, resulting in a powerful anti-tumor response in mice, according to a study by researchers at the National Cancer Institute, a part of the National Institutes of Health. This work represents an important advance in the development of immunotherapy for cancer and appears online June 14, 2009 in Nature Medicine.
The Parenteral Drug Association (PDA) today launched one of two surveys on Quality Culture Metrics as part of its continuing program to evaluate quality metrics that can inform the regulator's risk-based inspection programs.
Middle-to-older aged women who are naturally early to bed and early to rise are significantly less likely to develop depression, according to a new study by researchers at University of Colorado Boulder and the Channing Division of Network Medicine at Brigham and Women's Hospital in Boston.
The word hospice originated from the Latin hospitium, which means "to host or offer a place of shelter." In 2009, an estimated 1.56 million patients, more than 40 percent of deaths, received hospice services in the United States.
Impax Pharmaceuticals, the branded products division of Impax Laboratories, Inc. today announced that the U.S. Food and Drug Administration (FDA) has accepted for filing the Company's New Drug Application (NDA) for IPX066 for the treatment of idiopathic Parkinson's disease (PD) submitted to the Agency on December 21, 2011.
› Verified 8 days ago
Kathryn M Rodrigue, MS CCC/SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 209 Cherry St, Milford, CT 06460 Phone: 203-874-5437 | |
Haily Reatherford, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 209 Cherry St, Milford, CT 06460 Phone: 203-874-5437 | |
Sophia Dickson, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 209 Cherry St, Milford, CT 06460 Phone: 203-874-5437 | |
Jennifer Marie Bosma, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 209 Cherry St, Milford, CT 06460 Phone: 203-874-5437 | |
Bethany Preston, M.S., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 246 Housatonic Dr, Milford, CT 06460 Phone: 203-610-5032 | |
Mary Lee Mcguire, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 209 Cherry St, Milford, CT 06460 Phone: 203-874-5437 | |
Maria Yorgakaros, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 680 Boston Post Rd, Milford, CT 06460 Phone: 203-783-1997 Fax: 203-783-3997 |